About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Memorial Sloan Kettering Cancer Center
https://www.mskcc.org/healthcare-professionals
Refer a Patient to MSKCC:
mskcc.org/refer
COVID-19
Myeloma
Leukemia
Lymphoma
Hematologic Transplantation and Malignancies
Breast
Lung
Gastrointestinal
Genitourinary
Gynecologic
Skin
Head and Neck
Brain
General Oncology
Palliative Care
Events
MPN
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
M
2022 Inherited Breast Cancer Risk Assessment and Reduction: What's New
By
University of Kansas Cancer Center Post San Antonio Review
FEATURING
Mark Robson
By
University of Kansas Cancer Center Post San Antonio Review
FEATURING
Mark Robson
35 views
February 23, 2022
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Breast
06:55
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "EMBER Study - Imlunestrant+/-Everolimus or…
Feat.
K. Jhaveri
21:26
Memorial Sloan Kettering Cancer Center
Early Diagnosis and Updates in Breast Cancer
Feat.
V. Sacchini
27:27
Nebraska Oncology Society
ASCO 2022 HR+ Breast Cancer Updates
Feat.
C. Dang
05:51
Nebraska Oncology Society
ASCO 2022 on the Phase 3 DESTINY-Breast 03 Trial: HER2+ BC Updates
Feat.
C. Dang
09:47
Nebraska Oncology Society
ASCO 2022 on the Phase 3 KEYNOTE-522 Trial: TNBC Updates
Feat.
C. Dang
09:57
ASCO 2022 Conference Coverage
ASCO 2022 Preliminary Analysis of an Expanded Access Study of the Fi…
Feat.
C. Dang
01:06
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 Preliminary Analysis of an Expanded Acce…
Feat.
C. Dang
05:41
ecancer
ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan Doubles PFS in MB…
Feat.
S. Modi
05:57
ecancer
ASCO 2022 DESTINY-Breast04: Trastuzumab Deruxtecan vs. Treatment of …
Feat.
S. Modi
06:32
ASCO 2022 Conference Coverage
ASCO 2022 on Characterization of Alpelisib-Associated Hyperglycemia …
Feat.
S. Shen
01:37
ASCO 2022 Conference Coverage
Lecture Summary - ASCO 2022 on Characterization of Alpelisib-Associa…
Feat.
S. Shen
20:08
Memorial Sloan Kettering Cancer Center
HER2- Directed Targeted Agents for Brain Metastasis in Metastatic Br…
Feat.
N. Iyengar
28:05
University of Kansas Cancer Center Post San Antonio Review
2022 Inherited Breast Cancer Risk Assessment and Reduction: What…
Feat.
M. Robson
53:46
PleXus Communications
HR+ Breast Cancer: Individualizing Therapy With CDK 4/6 Inhibitors
Feat.
K. Jhaveri
07:16
SABCS 2021 Conference Coverage on VuMedi
SABCS 2021 Results of a Prospective Screening Study: Impact of Race …
Feat.
A. Barrio
13:08
SABCS 2021 Conference Coverage on VuMedi
SABCS 2021 Updates on Neratinib + Fulvestrant + Trastuzumab for HR+/…
Feat.
K. Jhaveri
24:21
SABCS 2021 Conference Coverage on VuMedi
SABCS 2021 Update on Oligoprogressive Disease in BC: Treating Locall…
Feat.
A. Xu
20:23
Memorial Sloan Kettering Cancer Center
Will Surgery Be a Part of Breast Cancer Treatment in the Future?
Feat.
M. Morrow
26:50
5th Annual Cleveland Breast Cancer Summit: Collaborating For A Cure
CAR-T Cell Therapy for Breast Cancer: Types of T-Cell Therapy, Ident…
Feat.
S. Modi
